Inovio Pharmaceuticals, Inc.

NASDAQ:INO

1.84 (USD) • At close December 20, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2023202220212020201920182017201620152014201320122011201020092008200720062005200420032002200120001999
Revenue 0.83210.2621.7757.4114.11230.48242.2235.36840.57210.45713.4674.1199.7956.1459.122.0984.8083.4685.4671.1670.0810.194.4535.0778.3
Cost of Revenue 3.5045.4964.73194.24588.0170000000000000.2250.2060001.9251.4581.2
Gross Profit -2.6724.766-2.956-86.834-83.90530.48242.2235.36840.57210.45713.4674.1199.7956.1459.122.0984.8083.2435.2611.1670.0810.192.5283.627.1
Gross Profit Ratio -3.2110.464-1.666-11.717-20.4051111111111110.9350.9621110.5680.7130.855
Reseach & Development Expenses 86.677187.651249.2494.24588.01795.25898.57388.71257.79234.09521.36917.98520.03213.2579.4085.759.6268.5111.4556.5492.1472.4660.466.9778.1
General & Administrative Expenses 47.58290.18553.75237.24827.20329.31528.2923.89218.06415.85813.64310.77811.98912.10813.66910.00611.088.085.9816.1294.5673.65805.6110
Selling & Marketing Expenses 0000000000000000000000000
SG&A 47.58290.18553.75237.24827.20329.31528.2923.89218.06415.85813.64310.77811.98912.10813.66910.00611.088.085.9816.1294.5673.6586.6235.6115.5
Other Expenses -1.704-3.8620.3433.4160.4960.3610.8070.1280.1780.348-45.6331.983009.2824,672,5277,547,5780.2250.2065.6032.0722.28200.5660.4
Operating Expenses 132.555277.836302.993131.493115.22124.573126.863112.60475.85649.95335.01228.76332.02125.36523.07815.75620.70616.81417.64212.6786.7146.1247.08313.15414
Operating Income -135.227-267.574-301.218-124.082-111.109-94.091-83.643-76.236-34.284-39.496-19.544-23.494-21.639-19.22-13.958-13.658-15.898-13.346-15.507-11.511-6.633-5.935-5.576-9.535-6.9
Operating Income Ratio -162.53-26.074-169.723-16.742-27.021-3.087-1.981-2.155-0.845-3.777-1.451-5.704-2.209-3.128-1.53-6.511-3.307-3.848-2.836-9.863-82.371-31.315-1.252-1.878-0.831
Total Other Income Expenses Net 0.109-10.079-2.006-38.808-9.701-0.707-4.5632.4963.0833.356-46.5393.7816.3341.507-10.5030.6933.4220.8670.0020.2486.6330.027-3.29-0.5972.935
Income Before Tax -135.117-277.653-303.224-162.89-120.809-94.798-88.206-73.74-31.201-36.14-66.084-19.713-12.948-17.713-24.461-13.609-12.477-14.485-15.505-0-0-5.908-8.866-10.132-6.6
Income Before Tax Ratio -162.399-27.056-170.854-21.979-29.38-3.11-2.089-2.085-0.769-3.456-4.907-4.786-1.322-2.883-2.682-6.488-2.595-4.176-2.836-0-0-31.174-1.991-1.995-0.795
Income Tax Expense 010.0112.16152.196-0.2572.171.756-4.623-2.098-3.72288.117-8.109-16.285-4.08311.713-0.742-8.116-0.8676.451-0.538-1.9890.05700.638-0.6
Net Income -135.117-287.664-305.385-215.086-120.552-96.968-88.206-73.74-29.188-36.122-66.028-19.669-15.253-17.614-24.411-12.966-11.204-12.479-15.297-10.973-4.665-5.965-8.866-9.6-6.6
Net Income Ratio -162.399-28.031-172.071-29.022-29.318-3.181-2.089-2.085-0.719-3.454-4.903-4.776-1.557-2.866-2.677-6.181-2.331-3.598-2.798-9.402-57.928-31.473-1.991-1.891-0.795
EPS -6.09-14.47-17.55-16.64-14.65-1.05-1.08-1.01-0.43-0.61-1.43-0.58-0.48-0.68-1.31-1.18-1.08-1.58-3.22-2.49-1.4-2.35-5.13-6.8-5.21
EPS Diluted -6.09-14.47-17.55-16.64-14.65-1.05-1.08-1.01-0.43-0.61-1.43-0.58-0.48-0.68-1.31-1.18-1.08-1.58-3.22-2.49-1.4-2.35-5.13-6.8-5.21
EBITDA -130.391-270.903-296.557-149.56-107.344-89.801-84.737-74.15-33.365-37.927-19.445-22.65-21.639-17.112-13.958-11.973-10.187-12.435-11.376-10.938-6.049-5.283-5.576-8.371-8.968
EBITDA Ratio -156.718-26.169-165.281-10.278-25.677-2.935-1.965-2.128-0.851-3.661.796-6.26-3.011-3.188-1.209-6.061-3.82-3.585-1.472-9.372-75.114-27.877-1.252-1.649-0.819